Prevention and treatment should be aimed at reducing the residual tumor tissue (surgical resection or transpupillary thermotherapy) or at neutralizing the released mediators (intravitreal anti-VEGF agents) [64]. The gene discussed is VEGFA; the disease is neoplasm.